Self-paced • 0.25 credits
About This Course
Indications for genetic testing for breast cancer risk are expanding and patients who previously would not meet criteria for testing may now qualify based on recent guidelines. While multi-gene panels can increase the likelihood of identifying a cancer predisposition gene, there are also associated risks and limitations that should be considered by patients and providers before genetic testing. In this course, you will practice communicating these benefits, risks and limitations to support shared decision-making with your patients about engaging in multi-gene panel testing.
CME Information and Disclosures
Jointly Provided by The Jackson Laboratory and the University of Connecticut School of Medicine Office of Community and Continuing Medical Education
Original Release: June 26, 2015
Renewal Date: April 23, 2020
Expiration Date: April 23, 2023
Practicing primary care providers as well as students and residents.
- Determine appropriateness of breast cancer genetic testing
- Communicate the benefits, risks and limitations of genetic testing for breast cancer risk, including multi-gene panel testing
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Connecticut School of Medicine and The Jackson Laboratory. The University of Connecticut School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Connecticut School of Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Claiming Your Credit
In order to claim credit 1) answer the pre-assessment questions, 2) work through the module content in its entirety, 3) successfully complete the post-assessment answering 2 out of 4 questions correctly and 4) complete the evaluation.
- Emily Edelman, MS, CGC – The Jackson Laboratory
- Therese Ingram, MA – The Jackson Laboratory
- Suzanne Levasseur, APRN – Westport Public Schools
- Kate Reed, MPH, ScM, CGC – The Jackson Laboratory
- Linda Steinmark, MS, CGC – The Jackson Laboratory
Conflict of Interest Policy
All faculty members participating in CME activities sponsored by the University of Connecticut School of Medicine are required to disclose to the program audience any actual or apparent conflict of interest related to the content of their presentations. Program planners have an obligation to resolve any actual conflicts of interest and share with the audience any safeguards put in place to prevent commercial bias from influencing the content.
Unless otherwise noted, the program planners and faculty do not have a financial interest/arrangement or affiliation with any organizations that could be perceived as a real or apparent conflict of interest in the context of the subject of this course. The following disclosures are reported that could be perceived as a real or apparent conflict of interest in the education program: Emily Edelman and Kate Reed receive salary support from Pfizer Inc. through an unrestricted quality improvement grant that focuses on improving ascertainment of hereditary breast cancer, provided by the American Community Cancer Centers and Pfizer Independent Grants for Learning & Change. In their roles as a planners and content authors, Ms. Edelman and Ms. Reed recused themselves from all deliberations relating to content related to the commercial entity with which they have financial interest and were not responsible for reviewing for bias any related content. All educational material has been peer-reviewed by external reviewers to assess for bias.
Actors are being used in this program and are presenting information that has been scripted for them. They were not involved with the educational content of this activity. The program does not discuss the off-labeled use of any product.
An earlier version of this program was supported by educational grants from The Maine Cancer Foundation and The Jackson Laboratory Director's Innovation Fund. There is no commercial support being received for this activity.
Audio speakers or headphones
Screen resolution of 800X600 or higher
Adobe Reader 5.0 or higher
For best performance in a mobile environment, please download the Canvas Mobile App for IOS and Android.
Should you have technical questions or questions regarding the content of the activity, please email Clinical and Continuing Education at the Jackson Laboratory.
All information in Cancer Genetic Clinical Education is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Cancer Genetic Clinical Education. Reliance on any information in Cancer Genetic Clinical Education is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Cancer Genetic Clinical Education.